Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide
February 24 2021 - 1:00PM
Business Wire
Kit to be available for purchase at Walgreens
without a prescription and will allow for greater access to
testing, helping reduce the spread of COVID-19 and improve the
health of communities
As part of Walgreens ongoing efforts to increase access to
COVID-19 testing in communities across the U.S., the company
announced today it has entered into an agreement with Labcorp™ to
sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits
over-the-counter in up to 6,000 Walgreens stores nationwide
beginning in spring of this year. Walgreens is making significant
strides to increase on-site testing capacity at more than 5,000
Walgreens pharmacy locations by April 1, with more than half of
sites located in socially vulnerable areas.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210224005843/en/
Walgreens to Make Pixel by Labcorp™
COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at
Stores Nationwide (Photo: Business Wire)
This kit will be Walgreens first over-the-counter COVID-19
testing option available for purchase in-store and is aimed to
address stores that do not currently have testing available
on-site. This builds upon Walgreens and Labcorp’s recent
announcement of Pixel by Labcorp™ COVID-19 PCR Test Home Collection
Kit availability on Walgreens Find Care®, a digital health platform
available on the Walgreens app and Walgreens.com. The addition of
this over-the-counter collection kit in-store will help to ensure
customers have access to testing solutions when and how they need
it – at-home, in-store or at one of Walgreens’ other conveniently
located testing sites.
“Increasing access to COVID-19 testing continues to be a
priority for Walgreens. Working with Labcorp, we can now offer
testing solutions at a majority of Walgreens locations nationwide,”
said John Standley, president, Walgreens. “This is another example
of the power of innovative collaboration to drive greater access to
care and products, and we look forward to continuing to work with
Labcorp to provide health products and services to our
communities.”
“Labcorp is pleased to extend our strategic collaboration with
Walgreens to now include over-the-counter sale of Pixel by Labcorp
COVID-19 PCR Test Home Collection Kit,” said Brian Caveney, M.D.,
chief medical officer and president, Labcorp Diagnostics. “This is
yet another convenient way for consumers to learn if they are
infected with COVID-19, which can help communities continue the
fight against this global pandemic.”
Customers will be able to purchase the Pixel by Labcorp COVID-19
PCR Test Home Collection Kit at the pharmacy counter without a
prescription at up to 6,000 Walgreens stores nationwide. Once
purchased, customers can self-administer the test collection using
a short nasal swab and send their sample back to Labcorp via
pre-paid FedEx Express Overnight. Once processed by Labcorp, test
results are accessed by the customer via the Pixel by Labcorp
website.
If a COVID-19 test is positive, a Labcorp-verified healthcare
staff member will contact individuals directly by phone or mail to
discuss next steps. Pixel by Labcorp has contracted with a
physician network to provide independent physician services for
consultation. The Pixel by Labcorp COVID-19 PCR Test Home
Collection Kit is not a substitute for visits to a healthcare
professional and is for use by adults 18 and older.
Labcorp’s COVID-19 PCR test has not been FDA cleared or approved
and has been authorized by the FDA under an emergency use
authorization only for the detection of nucleic acid from
SARS-CoV-2, not for any other viruses or pathogens. The test is
only authorized for the duration of the declaration that
circumstances exist justifying the authorization of emergency use
of in vitro diagnostic tests for detection and/or diagnosis of
COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. §
360bbb-3(b)(1), unless the authorization is terminated or revoked
sooner. Limited quantities available per store.
About Walgreens
Walgreens (www.walgreens.com) is included in the Retail Pharmacy
USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a
global leader in retail and wholesale pharmacy. As America’s most
loved pharmacy, health and beauty company, Walgreens purpose is to
champion the health and well-being of every community in America.
Operating more than 9,000 retail locations across America, Puerto
Rico and the U.S. Virgin Islands, Walgreens is proud to be a
neighborhood health destination serving approximately 8 million
customers each day. Walgreens pharmacists play a critical role in
the U.S. healthcare system by providing a wide range of pharmacy
and healthcare services. To best meet the needs of customers and
patients, Walgreens offers a true omnichannel experience, with
platforms bringing together physical and digital, supported by the
latest technology to deliver high-quality products and services in
local communities nationwide.
About Labcorp
Labcorp is a leading global life sciences company that provides
vital information to help doctors, hospitals, pharmaceutical
companies, researchers, and patients make clear and confident
decisions. Through our unparalleled diagnostics and drug
development capabilities, we provide insights and accelerate
innovations to improve health and improve lives. With more than
70,000 employees, we serve clients in more than 100 countries.
Labcorp (NYSE: LH) reported revenue of $14 billion in FY2020. Learn
more about us at www.Labcorp.com or follow us on LinkedIn and
Twitter @Labcorp.
Cautionary Note Regarding Forward-Looking Statements. All
statements in this release that are not historical are
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are not guarantees of future
performance and involve risks, assumptions and uncertainties,
including, but not limited to, related to the ability to achieve
target roll-out on schedule as well as those described in Item 1A
(Risk Factors) of Walgreens Boots Alliance, Inc.’s Form 10-K for
its fiscal year ending August 31, 2020, and in other documents that
Walgreens Boots Alliance, Inc. files or furnishes with the
Securities and Exchange Commission. Should one or more of these
risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially.
These forward-looking statements speak only as of the date they are
made. Walgreens Boots Alliance, Inc. and Pixel Labcorp do not
undertake, and expressly disclaim, any duty or obligation to update
publicly any forward-looking statement after the date of this
release, whether as a result of new information, future events,
changes in assumptions or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210224005843/en/
Emily Mekstan Walgreens Media Relations media@walgreens.com
Labcorp contact: Christopher Allman-Bradshaw Labcorp Media
Relations mailto:Media@labcorp.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2023 to Apr 2024